BioCentury
ARTICLE | Company News

Oryza Laboratories, Research Corporation Technologies deal

April 15, 2013 7:00 AM UTC

Oryza acquired an exclusive worldwide license to market Research Corp.'s solid-phase peptide synthesis reagents. The reagents are applicable to combinatorial chemistry and solution syntheses. ...